France Archives

Gensight gene therapy biotech bernard gilly labiotech

News and Trends 18 Apr 2016

ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy

While on a stop in New York, I had a chance to chat with Bernard Gilly, the founder and CEO of the Paris biotech GenSight. I wanted to learn more about the company, which is one of the only examples in the World using Gene therapy to treat specific and rare types of blindness. GenSight […]

April 18, 2016 - 6 minutesmins - By Philip Hemme

geneuro euronext multiple sclerosis biotech

News and Trends 16 Apr 2016

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

We last wrote about GeNeuro in January, when they announced the launch of an IPO for their Multiple Sclerosis phase IIb trial. Now, as of yesterday they are listed on the Euronext Paris market. GeNeuro (in Geneva) is developing therapies and diagnostic tools for diseases associated with the expression of the human endogenous retrovirus MSRV, such […]

April 16, 2016 - 2 minutesmins - By Dani Bancroft

Vibiosphen biotech infectious disease pierre fabre

News and Trends 15 Apr 2016

Pierre Fabre partners for Open Innovation in Infectious Disease

Pierre Fabre has a new partnership for its Open Innovation programme based on an extensive plant library. It will now count with VibioSphen to develop new phyto-chemicals to fight infectious diseases. Pierre Fabre is the 3rd largest Pharma in France, employing over 10,000 people and generating revenues of over €2Bn. Lately, this mid-sized company made efforts […]

April 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

frederic gault coral microbiome interview cancer biotech immunooncology palytoxin adc

News and Trends 14 Apr 2016

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

The dream of Coral Biome in France is to use marine coral species to develop therapies against Cancer. We had the chance to meet Fréderic Gault, the co-founder and CEO. With an Education in biology followed by a specialism in aquaculture engineering, Fréderic immediately understood the importance of corals and their therapeutic potential in human health. […]

April 14, 2016 - 5 minutesmins - By Marie Godar

cellnovo biotech diabetes medtech device horizon2020

News and Trends 13 Apr 2016

Mobile Pancreas to Change Life of Diabetics in New EU Programme

A new €4M European project brings a mobile insulin pump from France, computer models from Romania, and research from the UK & Spain together, in order to improve living with diabetes. Cellnovo, a MedTech split between France and the UK, was selected to participate in a new diabetes project funded by Horizon 2020, the EU grant […]

April 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Apr 2016

A New Cellular ‘Back Door’ has been found to fight Malaria

Paris & Strasbourg (France) researchers have discovered an ‘Achilles Heel’ for malaria: A specific molecule the parasite needs from the host. Could this spawn a new generation of Parasitic disease drugs? Malaria is a parasitic disease that was responsible for over 400,000 deaths worldwide just in 2015, according to the WHO – especially in sub-Saharan Africa. However, the current […]

April 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

medday multiple sclerosis neurodegenerative disease md1003

News and Trends 11 Apr 2016

French Biotech gets €34M to bring Multiple Sclerosis Drug to the US

MedDay (France) has raised €34M that should help pay a US phase III for its leading candidate for Multiple Sclerosis – as well as its commercial launch in Europe. Based in Paris, MedDay is a Biotech developing new drugs targeting brain metabolism to treat diseases of the nervous system. Its leading candidate, MD1003, has a mixed track record. […]

April 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

genfit primary billiary cholangitis elafibranor

News and Trends 31 Mar 2016

Beyond NASH: Genfit jumps into another Critical Liver Condition

Genfit is extending the applications of its star candidate, Elafibranor, to a second liver disease – Primary Biliary Cholangitis (PBC), a rare condition with high unmet medical needs. Genfit from Lille (France) has been in the spotlight because of its phase III candidate for NASH – something we discussed with its CEO, Jean-François Mouney. Apparently, all the […]

March 31, 2016 - 2 minutesmins - By Denise Neves Gameiro

plant technologies greentech sundew biotech pat1

News and Trends 31 Mar 2016

From Anti-Ageing Creams to Alzheimer’s, this Biotech ‘Milks’ Tropical Plants

What if a biotech company would run its business with plants as raw materials? We looked at the biotech Plant Advanced Technologies (PAT) (France) aims to push back the frontiers of plant ‘sourcing’, by producing industrial biomolecules in plants without killing them! Only a few thousand of plants are quite well exploited in green biotech over around 450,000 […]

March 31, 2016 - 6 minutesmins - By Nicolas Sainte-Foie

News and Trends 25 Mar 2016

Biotech of the Week: OSE Pharma, the ‘Significant’ Immunotherapy Player from Paris

This week, we head up full speed from Geneva with our eyes aiming towards Paris. Known for its beauty, bohemian lifestyle and, of course the Eiffel Tower, the Louvre and le baguette, Paris is also the home of OSE Pharma, our Biotech of the Week. City: Paris (France) Founded: 2012 Employees: N/A Financial Data: €24.3M total raised (as of […]

March 25, 2016 - 2 minutesmins - By Joachim Eeckhout

maat pharma autologous microbiome therapy

News and Trends 23 Mar 2016

French Microbiome Startup Gets €10M to Start Clinical Trials

MaaT Pharma (France) has raised €10M in a series A round, which will allow it to start clinical development of its autologous therapy for imbalance of the Gut Microbiome. MaaT Pharma is developing microbiome-based therapies with an autologous (self-sourced) approach. This means that the patient suffering from dysbiosis is treated with their own microbiome, samples of which were […]

March 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

hiv virus vaccine la provence retroviral biosahntech anrs

News and Trends 23 Mar 2016

No, this French Startup didn’t Discover the Cure for HIV…

This is the story of a French doctor and his start-ups which have been trying to develop a cure for HIV for the last 10 years. The problem resides in exaggerating, not publishing data…and then repeating this process again and again. Last week, the professor Erwann Loret and his start-up Biosantech did a press conference to announce new “breakthrough” […]

March 23, 2016 - 3 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

Pierre Fabre partners for Open Innovation in Infectious Disease

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

Mobile Pancreas to Change Life of Diabetics in New EU Programme

A New Cellular ‘Back Door’ has been found to fight Malaria

French Biotech gets €34M to bring Multiple Sclerosis Drug to the US

Beyond NASH: Genfit jumps into another Critical Liver Condition

From Anti-Ageing Creams to Alzheimer’s, this Biotech ‘Milks’ Tropical Plants

Biotech of the Week: OSE Pharma, the ‘Significant’ Immunotherapy Player from Paris

French Microbiome Startup Gets €10M to Start Clinical Trials

No, this French Startup didn’t Discover the Cure for HIV…

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!